Inhibition of neutral sodium absorption by a prostaglandin analogue in patients with cystic fibrosis

Gastroenterology

Volumn 127, Issue 1, 2004, Pages 65-72

  Coates Jr , Stephen W ^a   Högenauer, Christoph ^a,b   Santa Ana, Carol A ^a   Rosenblatt, Randall L ^c   Emmett, Michael ^a   Fordtran, John S ^a  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF GRAZ   (Austria)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

3 isobutyl1 methylxanthine; CF; CFTR; cystic fibrosis; cystic fibrosis transmembrane conductance regulator; IBMX

Indexed keywords

CALCIUM ION; CYCLIC AMP; ELECTROLYTE; MARKER; MISOPROSTOL; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN E1 DERIVATIVE; SODIUM; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CYSTIC FIBROSIS; FEMALE; HUMAN; IN VIVO STUDY; INFUSION; INTRACELLULAR SPACE; JEJUNUM; MALE; MEASUREMENT; PATIENT; PERFUSION; PRIORITY JOURNAL; SECRETION; SODIUM ABSORPTION; STEADY STATE; WATER ABSORPTION;

EID: 3242739559     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2004.03.064     Document Type: Article

References (36)

1. Field M., Rao M.C., Chang E.B. Intestinal electrolyte transport and diarrheal disease. N Engl J Med. 321:1989;800-806. and 879-883
2. Sullivan S.K., Field M. Ion transport across mammalian small intestine. Field M., Frizzell F.A. Handbook of physiology. 1991;287-301 American Physiological Society, Bethesda, MD. Section 6: the gastrointestinal system. Volume 4: intestinal absorption and secretion.
3. Sellin J.H. Intestinal electrolyte absorption and secretion. Feldman M., Friedman L.S., Sleisenger M.H. 7th ed. Sleisenger and Fordtran's gastrointestinal and liver disease. Volume 2:2002;1693-1714 Saunders, Philadelphia, PA
4. Field M. Intestinal ion transport and the pathophysiology of diarrhea. J Clin Invest. 111:2003;931-943
5. + influx in isolated intestinal epithelial cells. Am J Physiol. 243:1982;C107-C115
6. + absorption in a cystic fibrosis mouse model. Am J Physiol. 270:1996;G259-G267
7. Davis G.R., Santa Ana C.A., Morawski S., Fordtran J.S. Active chloride secretion in the normal human jejunum. J Clin Invest. 66:1980;1326-1333
8. Fordtran J.S., Rector F.C., Carter N.W. The mechanisms of sodium absorption in the human small intestine. J Clin Invest. 47:1968;884-900
9. Read N.W., Fordtran J.S. The role of intraluminal junction potentials in the generation of the gastric potential difference in man. Gastroenterology. 76:1979;932-938
10. Högenauer C., Santa Ana C.A., Porter J.L., Millard M., Gelfand A., Rosenblatt R.L., Prestidge C.B., Fordtran J.S. Active intestinal chloride secretion in human carriers of cystic fibrosis mutations an evaluation of the hypothesis that heterozygotes have subnormal active intestinal chloride secretion. Am J Hum Genet. 67:2000;1422-1427
11. Physicians' desk reference. 57th ed. :2003;3110-3112 Thomson PDR, Montvale, NJ
12. Turnberg L.A., Fordtran J.S., Carter N.W., Rector F.C. Mechanisms of bicarbonate absorption and its relationship to sodium transport in the human jejunum. J Clin Invest. 49:1970;548-556
13. Russo M.A., Högenauer C., Coates S.W., Santa Ana C.A., Porter J.P., Rosenblatt R.L., Emmett M., Fordtran J.S. Abnormal passive chloride absorption in cystic fibrosis jejunum functionally opposes the classic chloride secretory defect. J Clin Invest. 112:2003;118-125
14. Banwell J.G., Pierce N.F., Mitra R.C., Brigham K.L., Caranasos G.J., Keimowitz R.I., Fedson D.S., Thomas J., Gorbach S.L., Sack R.B., Mondal A. Intestinal fluid and electrolyte transport in human cholera. J Clin Invest. 49:1970;183-195
15. Petritsch W., Eherer A.J., Holzer-Petsche U., Hinterleitner T., Beubler E., Krejs G.J. Effect of cholera toxin on the human jejunum. Gut. 33:1992;1174-1178
16. Gaginella T.S. Eicosanoid-mediated intestinal secretion. Lebenthal E., Duffey M.E. Textbook of secretory diarrhea. 1990;15-30 Raven, New York
17. Corbett C.L., Isaacs P.E.T., Riley A.K., Turnberg L.A. Human intestine ion transport in vitro. Gut. 18:1977;136-140
18. Hubel K.A., Renquist K.S. Ion transport in normal and inflamed human jejunum in vitro changes with electrical field stimulation and theophylline. Dig Dis Sci. 35:1990;815-820
19. Berschneider H.M., Knowles M.R., Azizkhan R.G., Boucher R.C., Tobey N.A., Orlando R.C., Powell D.W. Altered intestinal chloride transport in cystic fibrosis. FASEB J. 2:1988;2625-2629
20. O'Loughlin E.V., Hunt D.M., Gaskin K.J., Stiel D., Bruzuszcak I.M., Martin H.C.O., Bambach C., Smith R. Abnormal epithelial transport in cystic fibrosis jejunum. Am J Physiol. 260:1991;G758-G763
21. Laurenza A., Sutkowski E.M., Seamon K.B. Forskolin a specific stimulator of adenlyl cyclase or a diterpene with multiple sites of action? Trends Pharmacol Sci. 10:1989;442-447
22. Bukhave K., Rask-Madsen J. Saturation kinetics applied to in vitro effects of low prostaglandin E2 and F2α concentrations on ion transport across human jejunal mucosa. Gastroenterology. 78:1980;32-42
23. Beubler E., Bukhave K., Rask-Madsen J. Significance of calcium for the prostaglandin E2-mediated secretory response to 5-hydroxytryptamine in the small intestine of the rat in vivo. Gastroenterology. 90:1986;1972-1977
24. + exchanger 3 (NHE3) requires an NHE3-E3KARP-α-actinin-4 complex for oligomerization and endocytosis. J Biol Chem. 277:2002;23714-23724
25. + absorbing cells. J Clin Invest. 88:1991;855-863
26. Weinman E.J., Steplock D., Donowitz M., Shenolikar S. NHERF associations with sodium-hydrogen exchanger isoform 3 (NHE3) and ezrin are essential for cAMP-mediated phosphorylation and inhibition of NHE3. Biochemistry. 39:2000;6123-6129
27. Grubb B.R. Ion transport across the jejunum in normal and cystic fibrosis mice. Am J Physiol. 268:1995;G505-G513
28. Drumm M. What happens to ΔF508 in vivo. J Clin Invest. 103:1999;1369-1370
29. Kälin N., ClaaS A., Sommer M., Puchelle E., Tummler B. ΔF508 CFTR protein expression in tissues from patients with cystic fibrosis. J Clin Invest. 103:1999;1379-1389
30. Mall M., Kreda S.M., Mengos A., Jensen T.J., Hirtz S., Seydewitz H.H., Yankaskas J., Kunzelmann K., Riordan J.R., Boucher R.C. The ΔF508 mutation results in loss of CFTR function and mature protein in native human colon. Gastroenterology. 126:2004;32-41
31. French P.J., van Doorninck J.H., Peters R., Verbeek E., Ameen N.A., Marino C.R., de Jonge H.R., Bijman J., Scholte B.J. A ΔF508 mutation in mouse cystic fibrosis transmembrane conductance regulator results in a temperature-sensitive processing defect in vivo. J Clin Invest. 98:1996;1304-1312
32. Grubb B.R., Boucher R.C. Pathophysiology of gene-targeted mouse models for cystic fibrosis. Physiol Rev. 79:(Suppl 1):1999;S193-S214
33. + exchange requires CFTR-mediated cell shrinkage of villus epithelium. Gastroenterology. 125:2003;1148-1163
34. Field M., Semrad C.E. Toxigenic diarrheas, congenital diarrheas, and cystic fibrosis disorders of intestinal ion transport. Annu Rev Physiol. 55:1993;631-655
35. Grubb B.R. Ion transport across the murine intestine in the absence and presence of CFTR. Comp Biochem Physiol. 118A:1997;277-282
36. Grubb B.R., Gabriel S.E. Intestinal physiology and pathology in gene-targeted mouse models of cystic fibrosis. Am J Physiol. 36:1997;G258-G266